PAX9 and cancer: In LUAD patients, higher expression of PAX9 is associated with poorer prognosis and enhanced tumor progression [187], while in cell lines it regulates significantly reduces cell proliferation, migration, and invasion, suggesting its role in promoting aggressive cancer behavior [186].